EUVIMEDEUVIMED entdecken
Open Access

Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants

Der Metabolismus der Arachidonsäure reguliert die Entwicklung der Retinopathie der Frühgeborenen bei Frühgeborenen

Saurabh Kumar iD, Satish Patnaik, Manjunath B Joshi, Neha Sharma, Tarandeep Kaur, Subhadra Jalali, Ramesh Kekunnaya, Aatish Mahajan iD, Subhabrata Chakrabarti iD, Inderjeet Kaur iD

Journal of Neurochemistry · 2024-09 · 168 (9) · 3171-3187

DOI: 10.1111/jnc.16190 ↗

Auf einen Blick

Bei extrem frühgeborenen Kindern mit ROP waren mehrere Metabolite und Enzyme des Arachidonsäurewegs verändert. Die Befunde sprechen für eine Beteiligung dieses Stoffwechselwegs an Neovaskularisation und Entzündung.

Fragestellung

Ist eine abnorme Metabolisierung des Arachidonsäurewegs mit schweren Stadien der Retinopathie der Frühgeborenen verbunden?

Methode

Gezielte Genexpressionsanalyse in Blut, Plazenta und humanen primären Netzhautzellkulturen sowie IHC in ROP-Retina; LC–MS in Glaskörperproben.

Ergebnisse

In Blut, Plazenta und Netzhaut waren Prostaglandin D2, Leukotrien B5 und die Enzyme CYP1B1, CYP2C8, COX2 und ALOX15 erhöht, EPHX2 war vermindert. Hypoxie-, Angiogenese- und Apoptose-Gene waren ebenfalls höher exprimiert.

Schlussfolgerung der Autor:innen

Die Ergebnisse zeigen eine starke Beteiligung von EPHX2 an der Regulation von retinaler Neovaskularisation und Entzündung und unterstreichen die Rolle des Arachidonsäuremetabolismus bei ROP.

Kernaussagen

  • ROP-Fälle zeigten veränderte Arachidonsäure-Metabolite und Enzyme
  • EPHX2 war in ROP-Fällen und hypoxischen Netzhautzellen vermindert
  • Die Autor:innen sehen den Arachidonsäureweg als potenzielles Ziel

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 29.07.2024. Verfasst von Saurabh Kumar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, India. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Arachidonic Acid, Infant, Premature. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hyderabad Eye Research Foundation, Impacting Research Innovation and Technology, Department of Biotechnology, Ministry of Science and Technology, India.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extremely preterm infants are at risk of developing retinopathy of prematurity (ROP), characterized by neovascularization and neuroinflammation leading to blindness. Polyunsaturated fatty acid (PUFA) supplementation is recommended in preterm infants to lower the risk of ROP, however, with no significant improvement in visual acuity. Reasonably, this could be as a result of the non‐consideration of PUFA metabolizing enzymes. We hypothesize that abnormal metabolism of the arachidonic acid (AA) pathway may contribute to severe stages of ROP. The present study investigated the AA‐metabolizing enzymes in ROP pathogenesis by a targeted gene expression analysis of blood (severe ROP = 70, No/Mild = 56), placenta (preterm placenta = 6, full term placenta = 3), and human primary retinal cell cultures and further confirmed at the protein level by performing IHC in sections of ROP retina. The lipid metabolites were identified by LC–MS in the vitreous humor (VH; severe ROP = 15, control = 15). Prostaglandins D2 ( p = 0.02), leukotrienes B5 ( p = 0.0001), 11,12‐epoxyeicosatrienoic acid ( p = 0.01), and lipid‐metabolizing enzymes of the AA pathway such as CYP1B1 , CYP2C8 , COX2 , and ALOX15 were significantly upregulated while EPHX2 was significantly (0.04) downregulated in ROP cases. Genes involved in hypoxic stress, angiogenesis, and apoptosis showed increased expression in ROP. An increase in the metabolic intermediates generated from the AA metabolism pathway further confirmed the role of these enzymes in ROP, while metabolites for EPHX2 activity were low in abundance. Inflammatory lipid intermediates were higher compared to anti‐inflammatory lipids in VH and showed an association with enzyme activity. Both the placenta of preterm infants who developed ROP and hypoxic retinal cultures showed a reduced expression of EPHX2 . These findings suggested a strong involvement of EPHX2 in regulating retinal neovascularization and inflammation. The study results underscore the role of arachidonic acid metabolism in the development of ROP and as a potential target for preventing vision loss among preterm‐born infants. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinopathy of PrematurityArachidonic AcidInfant, PrematureHumansInfant, NewbornFemaleMaleRetinaPregnancyCells, Cultured

Stichwörter der Autor:innen

angiogenesisarachidonic acidinflammationlipidretinopathy of prematuritysoluble epoxide hydrolase

Substanzen

Arachidonic Acid

Autor:innen und Institutionen

  • Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, India.
  • Manipal Academy of Higher Education, Manipal, India.
  • Department of Ageing Research, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
  • Smt. Kannuri Santhamma Centre for Vitreo Retinal Diseases, LV Prasad Eye Institute, Hyderabad, India.
  • Jasti V Ramanamma Children's Eye Care Centre, LV Prasad Eye Institute, Hyderabad, India.

ORCID-Profile: Saurabh Kumar, Aatish Mahajan, Subhabrata Chakrabarti, Inderjeet Kaur

Förderung

  • Hyderabad Eye Research Foundation
  • Impacting Research Innovation and Technology
  • Department of Biotechnology, Ministry of Science and Technology, India
  • DBT-Wellcome Trust India Alliance
  • Wellcome Trust DBT India Alliance
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Kumar, S., Patnaik, S., Joshi, M. B., Sharma, N., Kaur, T., Jalali, S., Kekunnaya, R., Mahajan, A., Chakrabarti, S., & Kaur, I. (2024). Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants. Journal of Neurochemistry, 168(9), 3171-3187. https://doi.org/10.1111/jnc.16190

Vancouver

Kumar S, Patnaik S, Joshi MB, Sharma N, Kaur T, Jalali S, et al. Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants. Journal of Neurochemistry. 2024;168(9):3171-3187. doi:10.1111/jnc.16190

BibTeX
@article{Kumar2024,
  author = {Kumar, Saurabh and Patnaik, Satish and Joshi, Manjunath B and Sharma, Neha and Kaur, Tarandeep and Jalali, Subhadra and Kekunnaya, Ramesh and Mahajan, Aatish and Chakrabarti, Subhabrata and Kaur, Inderjeet},
  title = {Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants},
  journal = {Journal of Neurochemistry},
  year = {2024},
  volume = {168},
  number = {9},
  pages = {3171--3187},
  doi = {10.1111/jnc.16190}
}
Kostenlos starten →